BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parisi A, Porzio G, Ficorella C. Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future. Cancers (Basel) 2020;12:E2598. [PMID: 32932914 DOI: 10.3390/cancers12092598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Gao M, Niu Y, Sun J. From DNMT1 degrader to ferroptosis promoter: Drug repositioning of 6-Thioguanine as a ferroptosis inducer in gastric cancer. Biochemical and Biophysical Research Communications 2022;603:75-81. [DOI: 10.1016/j.bbrc.2022.03.026] [Reference Citation Analysis]
2 Zhang XH, Guo Q, Wang HY, Li YH, Khamis MY, Ma LY, Wang B, Liu HM. Gramine-based structure optimization to enhance anti-gastric cancer activity. Bioorg Chem 2021;107:104549. [PMID: 33383324 DOI: 10.1016/j.bioorg.2020.104549] [Reference Citation Analysis]
3 Hu J, Yang S, Wang J, Zhang Q, Zhao L, Zhang D, Yu D, Jin M, Ma H, Liu H, Xue J, Zhang T. Blood alkaline phosphatase predicts prognosis of patients with advanced HER2-negative gastric cancer receiving immunotherapy. Ann Transl Med 2021;9:1316. [PMID: 34532453 DOI: 10.21037/atm-21-3376] [Reference Citation Analysis]
4 Ma Z, Xu J, Ru L, Zhu W. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis. Biosci Rep 2021;41:BSR20203676. [PMID: 33754626 DOI: 10.1042/BSR20203676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. J Clin Med 2021;10:1412. [PMID: 33915839 DOI: 10.3390/jcm10071412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]